" With current earnings expectations ( and guidance ) reflecting the impact of the Xopenex rate cut , the ruling 's suspension should prompt upward estimate revisions for AHG , LNCR , and ROHI ( Rotech Healthcare Inc ) , " Arthur Henderson , an analyst at Jefferies & Co. said .